ATC Group: J07AC01 Anthrax antigen

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07AC01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07A Bacterial vaccines
4 J07AC Anthrax vaccines
5 J07AC01 Anthrax antigen

Active ingredients in J07AC01

Active Ingredient Description
Anthrax antigen

Anthrax antigen induces antibodies raised against PA that may contribute to protection by neutralizing the activities of the cytotoxic lethal toxin and edema toxin of Bacillus anthracis.

Related product monographs

Title Information Source Document Type  
BIOTHRAX Suspension for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Poland (PL)

Singapore (SG)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.